{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:37:52Z","timestamp":1771677472520,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3309-2","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T09:20:22Z","timestamp":1494494422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response"],"prefix":"10.1186","volume":"17","author":[{"given":"Diego","family":"Teyssonneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaury","family":"Daste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Dousset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Hoepffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Ravaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Gross-Goupil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"issue":"Suppl 5","key":"3309_CR1","doi-asserted-by":"crossref","first-page":"v134","DOI":"10.1093\/annonc\/mdq175","volume":"21","author":"J Bellmunt","year":"2010","unstructured":"Bellmunt J, Orsola A, Maldonado X, Kataja V, ESMO Guidelines Working Group. Bladder cancer: ESMO practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v134\u20136.","journal-title":"Ann Oncol"},{"key":"3309_CR2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.6004\/jnccn.2013.0059","volume":"11","author":"PE Clark","year":"2013","unstructured":"Clark PE, Agarwal N, Biagioli MC, et al. Bladder cancer. J Natl Compr Cancer Netw. 2013;11:446\u201375.","journal-title":"J Natl Compr Cancer Netw"},{"key":"3309_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.urolonc.2012.08.015","volume":"32","author":"HM Bruins","year":"2014","unstructured":"Bruins HM, Skinner EC, Dorin RP, et al. Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study. Urol Oncol. 2014;32:24. e13-19","journal-title":"Urol Oncol"},{"key":"3309_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.nrl.0000219732.33321.cc","volume":"12","author":"MC Chamberlain","year":"2006","unstructured":"Chamberlain MC. Neoplastic meningitis. Neurologist. 2006;12:179\u201387.","journal-title":"Neurologist"},{"key":"3309_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","volume":"38","author":"M Miettinen","year":"2014","unstructured":"Miettinen M, Cue PAM, Sarlomo-Rikala M, et al. GATA 3 \u2013 a multispecific but potentially useful marker in surgical pathology \u2013 a systematic analysis of 2500 epithelial and non-epithelial tumors. Am J Surg Pathol. 2014;38:13\u201322.","journal-title":"Am J Surg Pathol"},{"key":"3309_CR6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0022-5347(17)49939-3","volume":"132","author":"PN Matthews","year":"1984","unstructured":"Matthews PN, Madden M, Bidgood KA, Fisher C. The clinicopathological features of metastatic superficial papillary bladder cancer. J Urol. 1984;132:904\u20136.","journal-title":"J Urol"},{"issue":"Suppl 7","key":"3309_CR7","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.1016\/S1166-7087(08)74557-3","volume":"18","author":"T Lebret","year":"2008","unstructured":"Lebret T, M\u00e9jean A. Rare locations of metastases from urothelial carcinoma. Prog En Urol. 2008;18(Suppl 7):S289\u201397.","journal-title":"Prog En Urol"},{"key":"3309_CR8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0090-4295(80)90067-9","volume":"16","author":"RJ Babaian","year":"1980","unstructured":"Babaian RJ, Johnson DE, Llamas L, Ayala AG. Metastases from transitional cell carcinoma of urinary bladder. Urology. 1980;16:142\u20134.","journal-title":"Urology"},{"key":"3309_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/02841860802325932","volume":"48","author":"C Jessen","year":"2009","unstructured":"Jessen C, Agerbaek M, Von Der Maase H. Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and\/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy. Acta Oncol. 2009;48:411\u20137.","journal-title":"Acta Oncol"},{"key":"3309_CR10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/030089161009600229","volume":"96","author":"D Uncu","year":"2010","unstructured":"Uncu D, Arpaci F, Beyzadeoglu M, et al. Meningeal carcinomatosis: an extremely rare involvement of urinary bladder carcinoma. Tumori. 2010;96:352\u20134.","journal-title":"Tumori"},{"key":"3309_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/157339411797642597","volume":"7","author":"T Leal","year":"2011","unstructured":"Leal T, Chang JE, Mehta M, Robins HI. Leptomeningeal Metastasis: challenges in diagnosis and treatment. Curr Cancer Ther Rev. 2011;7:319\u201327.","journal-title":"Curr Cancer Ther Rev"},{"key":"3309_CR12","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7","volume":"64","author":"CN Sternberg","year":"1989","unstructured":"Sternberg CN, Yagoda A, Scher HI, et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer. 1989;64:2448\u201358.","journal-title":"Cancer"},{"key":"3309_CR13","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","volume":"18","author":"H Maase von der","year":"2000","unstructured":"von der Maase H, Hansen SW, Roberts JT, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol. 2000;18:3068\u201377.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3309-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T05:52:58Z","timestamp":1569304378000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3309-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3309"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3309-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]},"article-number":"323"}}